XML 11 R5.htm IDEA: XBRL DOCUMENT v3.26.1
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Total Great Elm Group Inc. Stockholders' Equity
Redeemable Non-controlling Interest in Consolidated Funds
Beginning balance at Jun. 30, 2024 $ 70,195 $ 30 $ 3,315,638 $ (3,252,954) $ 62,714 $ 7,481
Beginning balance (in shares) at Jun. 30, 2024   30,494,000        
Net (loss) income 2,974     2,639 2,639 335
Issuance of common stock related to vesting of restricted stock (in shares)   528,000        
Distributions from Consolidated Funds (136)         (136)
Stock repurchases (2,109) $ (2) (2,107)   (2,109)  
Stock repurchases (in shares)   (2,279,000)        
Stock-based compensation 660   660   660  
Ending balance at Sep. 30, 2024 71,584 $ 28 3,314,191 (3,250,315) 63,904 7,680
Ending balance (in shares) at Sep. 30, 2024   28,743,000        
Net (loss) income 1,354     1,176 1,176 178
Issuance of common stock related to vesting of restricted stock (in shares)   139,000        
Distributions from Consolidated Funds (134)         (134)
Stock repurchases (3,122) $ (2) (3,120)   (3,122)  
Stock repurchases (in shares)   (1,732,000)        
Stock-based compensation 376   376   376  
Ending balance at Dec. 31, 2024 70,058 $ 26 3,311,447 (3,249,139) 62,334 7,724
Ending balance (in shares) at Dec. 31, 2024   27,150,000        
Net (loss) income (4,501)     (4,497) (4,497) (4)
Issuance of common stock related to vesting of restricted stock (in shares)   116,000        
Contributions to Consolidated Funds 500         500
Distributions from Consolidated Funds (132)         (132)
Stock repurchases (1,086) $ (1) (1,085)   (1,086)  
Stock repurchases (in shares)   (579,000)        
Stock-based compensation 476   476   476  
Ending balance at Mar. 31, 2025 65,315 $ 25 3,310,838 (3,253,636) 57,227 8,088
Ending balance (in shares) at Mar. 31, 2025   26,687,000        
Beginning balance at Jun. 30, 2025 $ 80,666 $ 25 3,310,356 (3,240,063) 70,318 10,348
Beginning balance (in shares) at Jun. 30, 2025 26,552,948 26,553,000        
Net (loss) income $ (7,904)     (7,030) (7,030) (874)
Issuance of common stock related to vesting of restricted stock (in shares)   430,000        
Withholding tax payments related to restricted stock (154)   (154)   (154)  
Issuance of common stock related to equity transactions, net 10,034 $ 5 10,029   10,034  
Issuance of common stock related to equity transactions, net (in shares)   5,354,000        
Issuance of warrants 726   726   726  
Distributions from Consolidated Funds (113)         (113)
Stock repurchases (756)   (756)   (756)  
Stock repurchases (in shares)   (252,000)        
Stock-based compensation 644   644   644  
Ending balance at Sep. 30, 2025 83,143 $ 30 3,320,845 (3,247,093) 73,782 9,361
Ending balance (in shares) at Sep. 30, 2025   32,085,000        
Beginning balance at Jun. 30, 2025 $ 80,666 $ 25 3,310,356 (3,240,063) 70,318 10,348
Beginning balance (in shares) at Jun. 30, 2025 26,552,948 26,553,000        
Issuance of warrants     700      
Ending balance at Mar. 31, 2026 $ 39,840 $ 28 3,316,383 (3,276,571) 39,840  
Ending balance (in shares) at Mar. 31, 2026 29,917,837 29,918,000        
Beginning balance at Sep. 30, 2025 $ 83,143 $ 30 3,320,845 (3,247,093) 73,782 9,361
Beginning balance (in shares) at Sep. 30, 2025   32,085,000        
Net (loss) income (16,548)     (15,754) (15,754) (794)
Issuance of common stock related to vesting of restricted stock (in shares)   140,000        
Issuance of common stock related to equity transactions, net (189)   (189)   (189)  
Distributions from Consolidated Funds (4,639)         (4,639)
Stock repurchases (2,640) $ (1) (2,639)   (2,640)  
Stock repurchases (in shares)   (1,061,000)        
Stock-based compensation 563   563   563  
Ending balance at Dec. 31, 2025 59,690 $ 29 3,318,580 (3,262,847) 55,762 3,928
Ending balance (in shares) at Dec. 31, 2025   31,164,000        
Net (loss) income (13,520)     (13,724) (13,724) 204
Issuance of common stock related to vesting of restricted stock (in shares)   125,000        
Issuance of common stock related to equity transactions, net 34   34   34  
Redemptions of non-controlling interests in Consolidated Funds (4,132)         $ (4,132)
Stock repurchases (2,823) $ (1) (2,822)   (2,823)  
Stock repurchases (in shares)   (1,371,000)        
Stock-based compensation 591   591   591  
Ending balance at Mar. 31, 2026 $ 39,840 $ 28 $ 3,316,383 $ (3,276,571) $ 39,840  
Ending balance (in shares) at Mar. 31, 2026 29,917,837 29,918,000